Connection
Erhan Ararat to Antineoplastic Agents
This is a "connection" page, showing publications Erhan Ararat has written about Antineoplastic Agents.
|
|
Connection Strength |
|
 |
|
 |
|
0.253 |
|
|
|
-
Ararat E, Sahin I, Ozdemir E, Altundag K. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. Br J Haematol. 2010 Dec; 151(5):530-1.
Score: 0.202
-
Sahin I, Ararat E, Altundag K. BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes? J BUON. 2011 Jan-Mar; 16(1):184-5.
Score: 0.051